Durable complete response in a patient with BRAF-mutated advanced melanoma with ocular and skin toxicities from BRAF/MEK targeted therapy after immune checkpoint inhibitor treatment: a case report. Dermatology Reports, [S. l.], 2025. DOI: 10.4081/dr.2025.10324. Disponível em: https://journals.pagepress.org/dr/article/view/10324. Acesso em: 18 jun. 2025.